학술논문

Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b
Document Type
Article
Source
In European Journal of Cancer September 2012 48(13):2012-2019
Subject
Language
ISSN
0959-8049